A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA)
Clinical trial NCT01904279 · COMPLETED
Trial details
- NCT number
- NCT01904279
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2016-05-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.